Clinical trials
Phase 3 trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16,498 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 197 |
| 2001 | 222 |
| 2002 | 310 |
| 2003 | 419 |
| 2004 | 542 |
| 2005 | 661 |
| 2006 | 726 |
| 2007 | 680 |
| 2008 | 727 |
| 2009 | 638 |
| 2010 | 659 |
| 2011 | 638 |
| 2012 | 610 |
| 2013 | 591 |
| 2014 | 612 |
| 2015 | 672 |
| 2016 | 584 |
| 2017 | 652 |
| 2018 | 736 |
| 2019 | 654 |
| 2020 | 645 |
| 2021 | 689 |
| 2022 | 614 |
| 2023 | 565 |
| 2024 | 557 |
| 2025 | 597 |
| 2026 | 596 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11,053 |
| Terminated | 1,928 |
| Recruiting | 1,395 |
| Active, not recruiting | 1,237 |
| Unknown status | 379 |
| Withdrawn | 293 |
| Not yet recruiting | 103 |
| Enrolling by invitation | 69 |
| Suspended | 41 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 455 |
| Pfizer | 427 |
| Novartis Pharmaceuticals | 398 |
| GlaxoSmithKline | 396 |
| Eli Lilly and Company | 376 |
| Hoffmann-La Roche | 311 |
| Sanofi | 299 |
| Novo Nordisk A/S | 231 |
| Bristol-Myers Squibb | 218 |
| National Cancer Institute (NCI) | 193 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 569 |
| Breast Neoplasms | 404 |
| Carcinoma, Non-Small-Cell Lung | 330 |
| Pain | 320 |
| Diabetes Mellitus | 305 |
| HIV Infections | 305 |
| Prostatic Neoplasms | 263 |
| Obesity | 255 |
| Neoplasms | 247 |
| Asthma | 246 |
Trials
Showing 26 to 50 of 16,498. Each trial links to its page on Pharma Observatory.
16,398 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.